- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
AllHealth teams with InSiteOne
InSiteOne of Wallingford, CT, has picked up AllHealth as a new partner. The shared-services alliance owned by healthcare providers has entered into an agreement to endorse and help market InSiteOne's InDex digital archiving service. The agreement will
InSiteOne of Wallingford, CT, has picked up AllHealth as a new partner. The shared-services alliance owned by healthcare providers has entered into an agreement to endorse and help market InSiteOne's InDex digital archiving service. The agreement will give AllHealth customers access to InSiteOne's array of medical image storage, archiving, and distribution technology services, enabling them to immediately begin digitally storing and retrieving diagnostic images. This is InSiteOne's first partnership with a group whose primary goal is to create purchasing value for healthcare organizations, according to Jeff Pasquale, InSiteOne's director of sales for the Eastern region. The Web-enabled InDex stores and distributes digital images for hospitals, imaging centers, and medical practices in the mid-Atlantic region.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
